Neuro-Bio

About:

Neuro-Bio is a British pharmaceutical company

Top Investors: Kairos Ventures

Description:

Neuro-Bio is a start-up company focused on the development of novel, effective therapeutics for neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Motor Neuron Disease. The Company’s uniqueness lies in its innovative identification of the initial trigger of neurodegeneration - this has been developed throughout Baroness Professor Susan Greenfield’s highly credited 40 year career in neuroscience.

Total Funding Amount:

$3.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Abingdon, Oxfordshire, United Kingdom

Founded Date:

2013-01-01

Contact Email:

info(AT)neuro-bio.com

Founders:

Susan Greenfield

Number of Employees:

11-50

Last Funding Date:

2017-03-28

IPO Status:

Private

Industries: